Universita' Degli Studi Dell'aquila

L'Aquila, Abruzzo Doing business as Univaq Part of Consiglio Nazionale Delle Ricerche

UEI
CKMHTLA9A2B5
CAGE
AH201
Primary NAICS
611310 Colleges, Universities, and Professional Schools
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Foreign Government
  • Educational Institution
  • State Controlled Institution of Higher Learning
Entity structure
Country - Foreign Government
Corporate family
  • Ipcb-Cnr Parent Consiglio Nazionale Delle Ricerche JJMDKZCTCDD8
    • Univaq
SAM.gov registration date
Physical address
Piazza Santa Margherita, 2, 67100 L'Aquila AQ, Italy
Website
univaq.it
Founded
1952
Employees
251-1K
Estimated annual revenue
$100M-$250M
Industry
  1. Consumer Discretionary
  2. Diversified Consumer Services
  3. Education Services
  4. Education
SIC code
82 Educational Services

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $0
FY2025 -$24,800

Contract awards

Award Agency Obligated Awarded
Universita'' degli studi dell'aquila:1218710 [20-037390] molecular and immune landscape and etiology of acral… 75N91020P00954 National Cancer Institute (NIH) $0
Universita'' degli studi dell''aquila - support the collection of patients with familial melanoma (at least two members… HHSN261201400496P National Cancer Institute (NIH) $24,500
Other functions - formalin fixed tissue blocks and melanoma lesion pathology reports HHSN261201200477P National Cancer Institute (NIH) $24,800

Grant awards

Award Agency Obligated Awarded
Entanglement distribution in fiber-optic quantum networks W911NF1820155 ACC Aberdeen Proving Ground $34,950
Funds for DR. Cristian antonelli to visit ARL-adelphi. DR. Antonelli will meet with researchers to discuss photon… W911NF1710439 ACC Aberdeen Proving Ground $10,569

Grant subawards

Prime recipient Prime award Amount Awarded
University Of Illinois Background: Schistosomiasis is a neglected parasitic disease affecting approx. 280 million people in the poor tropical and sub-tropical areas of the world.… R01AI177493 $54,000
Rush University Medical Center Identification of preclinical drug candidates for the treatment of schistosomiasis R33AI127635 $125,820
Rush University Medical Center Identification of preclinical drug candidates for the treatment of schistosomiasis R33AI127635 $111,240

Similar vendors

Vendor Location Primary NAICS
Alma Mater Studiorum - Universita' DI Bologna UEI XAMBTGCKDM13 Bologna, Emilia-Romagna 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Universita' Politecnica Delle Marche UEI FZHXK2JL7D23 Ancona, Marche 611310 Colleges, Universities, and Professional Schools
Dipartimento DI Elettronica E Informazione UEI E566LCLJAPD8 Milano, Lombardia 611310 Colleges, Universities, and Professional Schools
Unicen UEI S3RUJHALZVC9 Tandil, Provincia de Buenos Aires 611310 Colleges, Universities, and Professional Schools

See more similar vendors on GovTribe

About the company

Written by GovTribe AI ·

Universita' Degli Studi Dell'Aquila, commonly known as Univaq, is a foreign educational institution registered in the U.S. government's System for Award Management (SAM.gov) since 2008, with registration valid until February 2026. Located in L'Aquila, Italy, the university is classified as a state-controlled institution of higher learning and operates as a child entity within a larger organizational structure. As a foreign academic institution, Univaq provides specialized research and scientific services to U.S. federal agencies, with a primary focus on advanced scientific research in medical and biological domains.

Regarding federal contract awards, Univaq has a limited contract history, with one documented federal contract from the National Cancer Institute. This specific contract, awarded on September 15, 2020, was a purchase order valued at $24,800 for a research project titled "Molecular and Immune Landscape and Etiology of Acral Lentiginous Melanoma". The contract was not designated under any specific set-aside category and was completed by September 29, 2022. There are no additional prime federal contract awards recorded for this institution.

In terms of federal grant awards, Univaq has been more actively engaged, participating in sub-grant awards related to advanced medical research. The university has received two notable sub-grant awards: one from the University of Illinois on October 25, 2024, focusing on schistosomiasis research, and another from Rush University Medical Center on May 7, 2021, centered on identifying preclinical drug candidates for schistosomiasis treatment. The University of Illinois sub-grant involves complex structural biology research, including extensive work on thioredoxin glutathione reductase (TGR) from Schistosoma mansoni. The research involves advanced techniques such as protein expression, X-ray crystallography, and cryo-electron microscopy, with the goal of developing potential clinical inhibitors for treating this neglected parasitic disease.

Quick answers

Is Universita' Degli Studi Dell'aquila registered in SAM.gov?

Yes. Universita' Degli Studi Dell'aquila's SAM.gov registration is active through September 17, 2027.

What is Universita' Degli Studi Dell'aquila's most recent federal award?

Universita' Degli Studi Dell'aquila's most recent federal contract award is Universita'' degli studi dell'aquila:1218710 [20-037390] molecular and immune landscape and etiology of acral… (75N91020P00954), from National Cancer Institute (NIH), on September 15, 2020.

On GovTribe

See Universita' Degli Studi Dell'aquila's full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login